New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 

Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate. 

This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy. 

New research may help providers identify patterns on neuroimaging that could offer clues into how well patients are responding to antidepressant medications.

Many have touted smoking marijuana as a safer alternative to cigarettes. New imaging data offer clarity on whether this notion is actually true. 

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies.